Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary Evaluation
Last updated on April 2022Recruitment
- Recruitment Status
- Terminated
Exclusion Criteria
- pregnancy
- indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
- life expectancy < 6 months
- ...
- pregnancy
- indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
- life expectancy < 6 months
- allergy to contrast media
- refusal to provide informed consent or inability to follow up
- severe kidney disease (creatinine clearance < 30 mL min)
- prior history of ipsilateral DVT or femoral catheters
- the lesion cannot be accessed with the wire guide
Summary
- Conditions
- Deep Vein Thrombosis
- Venous Thromboembolism
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Exclusion Criteria
- pregnancy
- indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
- life expectancy < 6 months
- ...
- pregnancy
- indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
- life expectancy < 6 months
- allergy to contrast media
- refusal to provide informed consent or inability to follow up
- severe kidney disease (creatinine clearance < 30 mL min)
- prior history of ipsilateral DVT or femoral catheters
- the lesion cannot be accessed with the wire guide
Tracking Information
- NCT #
- NCT02066597
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Esteban Gandara, MD OHRI
- Esteban Gandara, MD OHRI
Get Well Soon